UnitedHealth Group (NYSE:UNH) Director Kenneth Irwin Shine sold 202 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, April 19th. The stock was sold at an average price of $237.42, for a total transaction of $47,958.84. Following the sale, the director now owns 28,948 shares of the company’s stock, valued at approximately $6,872,834.16. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.
UnitedHealth Group stock opened at $235.06 on Friday. UnitedHealth Group has a fifty-two week low of $166.65 and a fifty-two week high of $250.79. The company has a market cap of $228,136.20, a P/E ratio of 23.34, a PEG ratio of 1.36 and a beta of 0.77. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.73 and a current ratio of 0.71.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 17th. The healthcare conglomerate reported $3.04 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.91 by $0.13. UnitedHealth Group had a net margin of 5.41% and a return on equity of 22.06%. The firm had revenue of $55.19 billion for the quarter, compared to analyst estimates of $54.90 billion. During the same quarter in the previous year, the firm posted $2.37 earnings per share. The business’s revenue was up 13.3% on a year-over-year basis. analysts expect that UnitedHealth Group will post 12.61 EPS for the current fiscal year.
UNH has been the subject of several analyst reports. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $240.00 price target for the company in a research report on Tuesday, April 3rd. Deutsche Bank lifted their price target on shares of UnitedHealth Group to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, January 17th. Cantor Fitzgerald reiterated a “buy” rating and set a $235.00 price target on shares of UnitedHealth Group in a research report on Tuesday, January 16th. BMO Capital Markets lifted their price target on shares of UnitedHealth Group from $14.50 to $275.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 17th. Finally, Royal Bank of Canada reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday. Three research analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $251.13.
ILLEGAL ACTIVITY NOTICE: “Kenneth Irwin Shine Sells 202 Shares of UnitedHealth Group (UNH) Stock” was published by Week Herald and is the property of of Week Herald. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be viewed at https://weekherald.com/2018/04/22/kenneth-irwin-shine-sells-202-shares-of-unitedhealth-group-unh-stock.html.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.